The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity

Immune thrombocytopenia (ITP) treatment has evolved recently. However, none of the treatments have only benefits without drawbacks. This study aimed to compare the clinical outcomes and adverse drug patterns of Eltrombopag, Romiplostim, Prednisolone + Azathioprine, High Dose-dexamethasone (HD-DXM) (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamed, Eman Mostafa, Ibrahim, Ahmed R. N., Meabed, Mohamed Hussein, Khalaf, Ahmed M., El Demerdash, Doaa Mohamed, Elgendy, Marwa O., Saeed, Haitham, Salem, Heba F., Rabea, Hoda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303883/
https://www.ncbi.nlm.nih.gov/pubmed/37375815
http://dx.doi.org/10.3390/ph16060868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303883/
https://www.ncbi.nlm.nih.gov/pubmed/37375815
http://dx.doi.org/10.3390/ph16060868

Ejemplares similares